Daniel Stauder
Stock Analyst at JMP Securities
(1.83)
# 2,975
Out of 4,827 analysts
17
Total ratings
31.25%
Success rate
-3.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Market Outperform | $33 | $28.53 | +15.67% | 4 | May 6, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $31.18 | +92.43% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $4.65 | +50.54% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $81.48 | +35.00% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $686.83 | +5.56% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $12.58 | - | 1 | May 7, 2024 |
Artivion
May 6, 2025
Reiterates: Market Outperform
Price Target: $33
Current: $28.53
Upside: +15.67%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $31.18
Upside: +92.43%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $4.65
Upside: +50.54%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $81.48
Upside: +35.00%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $686.83
Upside: +5.56%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.58
Upside: -